A vaccine for human babesiosis: prospects and feasibility

被引:5
作者
Al-Nazal, Hanan [1 ]
Low, Leanne M. [2 ]
Kumar, Sanjai [3 ]
Good, Michael F. [1 ]
Stanisic, Danielle I. [1 ]
机构
[1] Griffith Univ, Inst Glyc, Gold Coast Campus, Griffith, Qld, Australia
[2] Natl Inst Allergy & Infect Dis, NIH, Lab Malaria & Vector Res, Rockville, MD USA
[3] FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Res & Review, Silver Spring, MD USA
基金
英国医学研究理事会;
关键词
RHOPTRY NECK PROTEIN-2; MICROTI INFECTION; BOVINE BABESIOSIS; GAMMA-INTERFERON; PROTECTIVE IMMUNITY; MALARIA PARASITE; T-CELLS; ANTIGENS; CATTLE; CANIS;
D O I
10.1016/j.pt.2022.07.005
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Babesiosis is a tick-borne disease caused by intraerythrocytic Babesia parasites. It is a well-known illness in companion animals and livestock, resulting in substan-tial economic losses in the cattle industry. Babesiosis is also recognized as an emerging zoonosis of humans in many countries worldwide. There is no vaccine against human babesiosis. Currently, preventive measures are focused on vector avoidance. Although not always effective, treatment includes antimicrobial therapy and exchange transfusion. In this review, we discuss the host's immune response to the parasite, vaccines being used to prevent babesiosis in animals, and lessons from malaria vaccine development efforts to inform the development of a human babesiosis vaccine. An effective human vaccine would be a significant advance towards curtailing this rapidly emerging disease.
引用
收藏
页码:904 / 918
页数:15
相关论文
共 100 条
[1]   Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosis [J].
Al-Nazal, Hanan A. ;
Cooper, Emily ;
Ho, Mei Fong ;
Eskandari, Sharareh ;
Majam, Victoria ;
Giddam, Ashwini Kumar ;
Hussein, Waleed M. ;
Islam, Md Tanjir ;
Skwarczynski, Mariusz ;
Toth, Istvan ;
Kumar, Sanjai ;
Zaid, Ali ;
Batzloff, Michael ;
Stanisic, Danielle, I ;
Good, Michael F. .
CELL HOST & MICROBE, 2021, 29 (06) :894-+
[2]   Host Immune Responses to Salivary Components-A Critical Facet of Tick-Host Interactions [J].
Ali, Abid ;
Zeb, Ismail ;
Alouffi, Abdulaziz ;
Zahid, Hafsa ;
Almutairi, Mashal M. ;
Ayed Alshammari, Fahdah ;
Alrouji, Mohammed ;
Termignoni, Carlos ;
Vaz Junior, Itabajara da Silva ;
Tanaka, Tetsuya .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
[3]   An Overview of Current Knowledge onin vitro BabesiaCultivation for Production of Live Attenuated Vaccines for Bovine Babesiosis in Mexico [J].
Alvarez, J. Antonio ;
Rojas, Carmen ;
Figueroa, Julio V. .
FRONTIERS IN VETERINARY SCIENCE, 2020, 7
[4]   Immunization of Bos taurus Steers with Babesia bovis Recombinant Antigens MSA-1, MSA-2c and 12D3 [J].
Antonio Alvarez, J. ;
Lopez, U. ;
Rojas, C. ;
Borgonio, V. M. ;
Sanchez, V. ;
Castaneda, R. ;
Vargas, P. ;
Figueroa, J. V. .
TRANSBOUNDARY AND EMERGING DISEASES, 2010, 57 (1-2) :87-90
[5]   Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis [J].
Bastos, Reginaldo G. ;
Alzan, Heba F. ;
Rathinasamy, Vignesh A. ;
Cooke, Brian M. ;
Dellagostin, Odir A. ;
Barletta, Raul G. ;
Suarez, Carlos E. .
VACCINES, 2022, 10 (01)
[6]   Persistence of Babesia microti Infection in Humans [J].
Bloch, Evan M. ;
Kumar, Sanjai ;
Krause, Peter J. .
PATHOGENS, 2019, 8 (03)
[7]   STUDIES ON FAILURE OF T-STRAIN LIVE BABESIA-BOVIS VACCINE [J].
BOCK, RE ;
DEVOS, AJ ;
KINGSTON, TG ;
FRASER, IR .
AUSTRALIAN VETERINARY JOURNAL, 1995, 72 (08) :296-300
[8]   Immunity following use of Australian tick fever vaccine: a review of the evidence [J].
Bock, RE ;
De Vos, AJ .
AUSTRALIAN VETERINARY JOURNAL, 2001, 79 (12) :832-839
[9]   INVESTIGATIONS OF BREAKDOWNS IN PROTECTION PROVIDED BY LIVING BABESIA-BOVIS VACCINE [J].
BOCK, RE ;
DEVOS, AJ ;
KINGSTON, TG ;
SHIELS, IA ;
DALGLIESH, RJ .
VETERINARY PARASITOLOGY, 1992, 43 (1-2) :45-56
[10]   Experimental Infection of Ticks: An Essential Tool for the Analysis of Babesia Species Biology and Transmission [J].
Bonnet, Sarah, I ;
Nadal, Clemence .
PATHOGENS, 2021, 10 (11)